Kissing Disease Linked to Higher Multiple Sclerosis Risk in Major Study
Waking up with crushing fatigue, a high fever, a raw throat, and swollen glands might signal more than just a common illness. According to new research, these symptoms could be linked to infectious mononucleosis, often called the 'kissing disease,' which may increase the risk of developing multiple sclerosis (MS) later in life.
The Epstein-Barr Virus Connection
Infectious mononucleosis is caused by the Epstein-Barr Virus (EBV), one of the most common human infections worldwide. The virus spreads primarily through saliva, not just through kissing but also through everyday close contact. While EBV infects most people at some point, only a small percentage develop mononucleosis with noticeable symptoms.
Groundbreaking Research Findings
A comprehensive US study utilizing records from the Mayo Clinic-led Rochester Epidemiology Project has revealed significant findings. The research tracked nearly 19,000 individuals and discovered that those who developed mononucleosis were over three times more likely to develop multiple sclerosis later in life compared to those without the infection.
The study showed:
- MS risk was 0.17% among those with mononucleosis
- MS risk was 0.07% among those without the infection
- The disease also appeared earlier in those who had been infected with EBV
Despite the increased relative risk, experts emphasize that the absolute risk remains small. Multiple sclerosis is a chronic condition where the immune system attacks the protective covering of nerves, disrupting communication between the brain and body. Initial symptoms can include fatigue, vision problems, numbness, and imbalance, potentially worsening over time.
Expert Perspectives on the Link
Medical professionals caution that while the association is strong, it does not imply causation. Dr. Sudhir Kumar, a neurologist at Apollo Hospital in Hyderabad, explained that the apparent rise in younger MS cases likely reflects better awareness and earlier MRI-based diagnosis rather than a true shift in disease onset.
"EBV may act as a trigger in genetically susceptible individuals, but it is not sufficient on its own to cause MS," Dr. Kumar stated. He added that it remains unclear whether earlier EBV infection leads to earlier disease manifestation in practice.
Dr. Kumar also advised against routine long-term monitoring after mononucleosis, noting that the absolute risk is low and excessive testing could cause unnecessary anxiety.
Understanding Multiple Sclerosis Risk Factors
Professor Manjari Tripathi, head of neurology at AIIMS in Delhi, highlighted that EBV is widespread in India, particularly among children and adolescents. She emphasized that MS is a complex disease with multiple contributing factors.
"MS involves genetic, environmental, and immune risk factors. EBV may act as a trigger, but it is not the sole cause, and most people with the infection will never develop MS," Professor Tripathi explained.
Early Detection and Prevention Strategies
Awareness of early symptoms is crucial for timely intervention. Neurological symptoms that should prompt medical evaluation include:
- Blurred or painful vision
- Tingling or numbness
- Unexplained fatigue
- Brief weakness episodes
- Balance problems
- Shock-like sensations down the spine
These symptoms are often missed because they may come and go, but any neurological symptom lasting more than 24 hours warrants professional assessment.
Future Implications and Vaccine Development
Scientists say these findings strengthen the case for preventive strategies, including the potential development of an EBV vaccine. While current research establishes a clear association between mononucleosis and MS risk, further studies are needed to understand the precise mechanisms and develop targeted interventions.
The research underscores the importance of recognizing early symptoms and maintaining awareness about the complex relationship between common viral infections and neurological conditions, while reassuring that the absolute risk remains minimal for most individuals.
